Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$16.09
+0.6%
$14.42
$12.00
$18.68
$99.25M118,223 shs44,791 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.62
-3.9%
$0.84
$0.57
$1.39
$48.48M0.8118,097 shs48,681 shs
Nephros Inc. stock logo
NEPH
Nephros
$3.45
-2.3%
$3.34
$1.36
$5.00
$37.42M1.0918,550 shs11,664 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.33
+3.1%
$4.72
$4.01
$9.33
$69.07M1.29187,987 shs69,063 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
+0.56%+4.08%+13.23%+31.35%-7.42%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-3.92%-9.81%-29.80%-31.43%-30.58%
Nephros Inc. stock logo
NEPH
Nephros
-2.27%-7.51%+1.47%+76.11%+56.82%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.10%-5.66%-10.17%-5.66%-27.71%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
1.2272 of 5 stars
0.03.00.00.01.90.81.9
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
2.9853 of 5 stars
3.55.00.00.01.92.50.0
Nephros Inc. stock logo
NEPH
Nephros
2.7621 of 5 stars
3.55.00.00.02.70.80.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.0625 of 5 stars
3.50.00.00.02.20.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3.00
Buy$1.25102.33% Upside
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.0044.93% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67169.44% Upside

Current Analyst Ratings Breakdown

Latest NEPH, FONR, MLSS, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.97$3.09 per share5.20$24.78 per share0.65
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$8.61M5.63N/AN/A$0.11 per share5.62
Nephros Inc. stock logo
NEPH
Nephros
$15.52M2.36$0.02 per share176.40$0.81 per share4.26
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.70$0.45 per share9.72$3.41 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.87N/A8.19%5.31%3.97%9/25/2025 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.07N/AN/A-52.01%-60.26%-40.23%N/A
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.0749.29N/A5.16%9.43%7.20%8/6/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1043.3018.83N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest NEPH, FONR, MLSS, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01N/AN/AN/A$9.30 millionN/A
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
2.85
1.86
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.92
4.64
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
24.75%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
3078.48 million58.61 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$16.09 +0.09 (+0.56%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$16.08 -0.01 (-0.06%)
As of 07/16/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Milestone Scientific stock logo

Milestone Scientific NYSE:MLSS

$0.62 -0.03 (-3.93%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$0.62 0.00 (-0.13%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Nephros stock logo

Nephros NASDAQ:NEPH

$3.45 -0.08 (-2.27%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$3.48 +0.03 (+0.87%)
As of 07/16/2025 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.33 +0.13 (+3.10%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$4.40 +0.07 (+1.62%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.